Home » Bayer Starts Phase III Study of Lung Drug Riociguat
Bayer Starts Phase III Study of Lung Drug Riociguat
Bayer AG has entered phase III of testing its experimental pulmonary-hypertension drug riociguat after the pill showed promise in an earlier trial, the company said.
CNBC
CNBC
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May